Market Overview

A Wild 24 Hours For Co-Diagnostics

Share:
A Wild 24 Hours For Co-Diagnostics

Shares of nano-cap Co-Diagnostics Inc (NASDAQ: CODX), which uses its proprietary technology to design tests to locate genetic markers used by biotech companies, swung wildly in the past 24 hours.

Co-Diagnostics shares more than doubled Wednesday from $1.11 to $2.24 only to give back much of the gains Thursday.

Preferred Share Sale

The company announced Wednesday morning a transaction that will effectively eliminate its debt, and the sale of $1 million in preferred shares. The transaction to eliminate debt involved conversion of a $2 million note to preferred stock.

Together, the company said it will sell $3 million of preferred shares, convertible to common stock at $1.20 per share.

"This financing benefits our shareholders by providing additional capital to accelerate our growth strategy," said CEO Dwight Egan.

Direct Offering

Souring sentiment on Thursday was an announcement that it entered into definitive agreements with institutional investors for selling about 3.93 million shares at a price of $1.40 per in a registered direct offering.

The company expects to generate gross proceeds of about $5.5 million from the offering, which is expected to close on or about Feb. 4.

Co-Diagnostics shares were down 38.84 percent to $1.37 at time of publication. The company has a $17.6 million market cap.

Related Links:

Daily Biotech Pulse: Hologic, Celgene Earnings, FDA To Rule On Alkermes Depression Drug

JMP Upgrades Intercept Pharma Ahead Of NASH Trial Data

Posted-In: Dwight EganNews Financing Offerings Movers Trading Ideas Best of Benzinga

 

Related Articles (CODX)

View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Bill Miller Boosts Avon, Coty Stocks

48 Stocks Moving In Thursday's Mid-Day Session